Revenue and Profit - The company's revenue for Q1 2024 was CNY 408,557,558.49, representing a 24.20% increase compared to CNY 328,954,250.75 in the same period last year[5] - Net profit attributable to shareholders decreased by 3.77% to CNY 35,777,065.98 from CNY 37,177,144.90 year-on-year[5] - Net profit for Q1 2024 was ¥39.30 million, representing a 5.7% increase compared to ¥37.18 million in Q1 2023[19] - Earnings per share (EPS) for Q1 2024 was ¥0.30, slightly down from ¥0.31 in the previous year[20] Cash Flow - The net cash flow from operating activities improved significantly, reaching CNY 23,329,490.77, a 140.89% increase from a negative CNY 57,051,716.49 in the previous year[10] - The net cash flow from operating activities for Q1 2024 was ¥23,329,490.77, a significant improvement compared to a net outflow of ¥57,051,716.49 in Q1 2023, indicating a turnaround in operational efficiency[23] - Cash flow from operating activities was ¥425.98 million, compared to ¥350.44 million in the prior period[22] - The total cash and cash equivalents at the end of Q1 2024 stood at ¥662,690,779.29, down from ¥828,668,997.35 at the end of Q1 2023, representing a decrease of approximately 20%[23] Assets and Liabilities - The company's total assets increased by 3.40% to CNY 3,380,781,932.69 from CNY 3,269,582,658.49 at the end of the previous year[5] - The company's total liabilities decreased by 4.46% in accounts payable, amounting to CNY 637,606,973.36 compared to CNY 667,389,375.38 at the end of the previous year[9] - The total liabilities increased to ¥1.18 billion, up from ¥1.17 billion year-over-year[19] - Total equity attributable to shareholders rose to ¥2.14 billion, compared to ¥2.10 billion in the previous year[19] Expenses - The company reported a significant increase in management expenses by 55.05%, totaling CNY 19,648,984.93, attributed to share-based payment expenses and increased operational costs[10] - Operating costs amounted to ¥367.78 million, up 25.5% from ¥292.94 million year-over-year[18] - Research and development expenses were ¥16.82 million, a decrease of 10.9% from ¥18.87 million in the same period last year[19] - Cash paid to employees increased to ¥38,713,193.13 in Q1 2024 from ¥31,040,274.17 in Q1 2023, reflecting a rise of approximately 25%[23] Shareholder Information - Total number of common shareholders at the end of the reporting period is 12,791[12] - The largest shareholder, Jiangsu Shangkun Biological Equipment Co., Ltd., holds 29.08% of shares, totaling 34,890,248 shares[12] Investment Activities - The company’s investment activities generated a net cash outflow of CNY 96,839,666.81, a 160.12% decrease compared to a net inflow of CNY 161,071,448.98 in the previous year[10] - Total cash inflow from investment activities decreased to ¥350,462,070.49 in Q1 2024 from ¥663,583,762.84 in Q1 2023, reflecting a decline of approximately 47%[23] - The net cash flow from investment activities was negative at -¥96,839,666.81 for Q1 2024, contrasting with a positive net flow of ¥161,071,448.98 in the same period last year[23] - The company did not report any cash inflow from new investments or acquisitions during Q1 2024, indicating a potential focus on consolidating existing operations[23] Other Financial Metrics - The weighted average return on equity decreased slightly to 1.69% from 1.89% year-on-year[5] - The company reported a total of CNY 3,599,682.71 in non-recurring gains and losses for the quarter[8] - The company received tax refunds totaling ¥4,254,328.59 in Q1 2024, compared to ¥4,720,258.08 in Q1 2023, showing a slight decline[23] - The first quarter report was not audited, which may impact the perceived reliability of the financial data presented[24]
通灵股份(301168) - 2024 Q1 - 季度财报